Castle Biosciences Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 22.79M51.87M62.65M94.08M137.04M219.79M332.07M
Cost of Revenue 5.30M7.31M9.69M15.82M32.01M44.98M60.20M
Gross Profit 17.49M44.55M52.96M78.26M105.03M174.81M271.86M
Operating items
Amortization - Intangibles 2.00M8.30M9.01M11.11M
Research & Development 4.85M7.38M13.26M29.65M44.90M53.62M52.04M
Selling, General & Administrative 16.47M29.84M48.13M86.74M143.00M180.15M200.05M
Other Operating Expenses 1.88M17.78M21.99M53.99M71.31M
Operating Expenses 21.32M37.23M69.19M134.16M209.89M287.76M323.40M
Operating Income -3.84M7.33M-6.54M-40.08M-72.86M-67.98M8.67M
EBIT -3.84M7.33M-6.54M-40.08M-72.86M-67.98M8.67M
Non-operating items
Interest & Investment Income 0.02M0.31M0.37M0.07M3.97M10.62M12.92M
Other Non Operating Income -0.27M5.21M-1.40M
Non Operating Income -0.27M-2.93M
Net income details
EBT -6.36M5.35M-10.20M-40.01M-68.90M-57.37M21.56M
Tax Provisions 0.01M0.07M0.08M-8.72M-1.77M0.10M3.32M
Profit After Tax -6.37M5.28M-10.28M-31.29M-67.14M-57.47M18.25M
Equity Income 0.60M
Income from Continuing Operations -6.37M5.28M-10.28M-31.29M-67.14M-57.47M18.25M
Consolidated Net Income -6.37M5.28M-10.28M-31.29M-67.14M-57.47M18.25M
Income towards Parent Company -6.37M5.28M-10.28M-31.29M-67.14M-57.47M18.25M
Preferred Dividend Payments 3.58M2.16M
Net Income towards Common Stockholders -10.16M2.99M-10.28M-31.29M-67.14M-57.47M18.25M
Additional items
EPS (Basic) -0.00M0.00M-0.00M-0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 15.46M17.07M19.91M25.30M26.35M26.91M28.01M
Shares Outstanding (Diluted Average) 1.91M8.66M18.93M25.14M26.05M26.80M29.25M
EBITDA -6.37M5.28M-10.28M-31.29M-72.86M-67.98M8.67M
Tax Rate 1.35%21.79%2.56%15.39%